Inspire Medical Systems, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Timothy Herbert
- Full Time Employees
- 1,333
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 5500 Wayzata Boulevard Golden Valley MN United States of America 55416
- IPO Date
- May 3, 2018
- CIK
- 0001609550
- Website
- inspiresleep.com
- Similar Companies
- Business
- Inspire Medical Systems, Inc. (NYSE: INSP) develops and commercializes the Inspire therapy, an implantable neurostimulation system designed to treat moderate to severe obstructive sleep apnea (OSA) in adult patients unable to use or get consistent benefit from continuous positive airway pressure (CPAP) devices. The company's core products and services include the Inspire Upper Airway Stimulation (UAS) system, consisting of the Inspire implantable pulse generator (IPG), stimulation lead, sensing lead, and external patient remote control; surgical tools and accessories for implantation; the myInspire patient management platform for remote monitoring and therapy adjustments; and physician and patient education programs supporting therapy adoption. Inspire therapy offers a masked volume reduction alternative to CPAP, with implantation performed by ENTs and sleep surgeons in outpatient procedures; the company provides direct-to-consumer marketing, reimbursement support services, and post-market clinical research through its registry studies. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems operates primarily in the United States, with expanding commercial presence in Europe (including select countries via partnerships) and international markets targeting adult OSA patients underserved by traditional therapies. The company serves sleep clinics, ENT practices, hospitals, and sleep surgeons as key customers, focusing on the medical device segment of the sleep health industry valued at billions annually. In recent developments, Inspire Medical Systems reported strong revenue growth in 2025, driven by increased procedure volumes and market adoption; the company expanded its European operations through new regulatory approvals and partnerships in 2024-2025. It launched enhancements to the Inspire therapy platform, including software updates for improved therapy titration and remote monitoring capabilities; additionally, Inspire announced positive results from ongoing post-market studies demonstrating long-term efficacy and safety, supporting expanded indications. No major acquisitions, funding rounds, or name changes were reported in the last 1-2 years, with strategic focus remaining on U.S. market penetration and international scaling.
Assenagon Asset Management S.A. Increases Holdings in Inspire Medical Systems, Inc. $INSP
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors
Amundi Sells 107,792 Shares of Inspire Medical Systems, Inc. $INSP
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call Transcript
Inspire Medical Systems Q2 Earnings Call Highlights
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
Inspire Medical Systems (INSP) Q2 Earnings and Revenues Beat Estimates
Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan
Inspire Medical Systems, Inc. $INSP Stake Boosted by Bank of Nova Scotia
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
3 Medical Device Stocks Giving Investors a Different Healthcare Play
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP